Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts

In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world’s largest pharmaceutical company announced large research and development cuts were on…

Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What’s ahead …

General Electric to Invest $2 Billion in China

The conglomerate said Tuesday that it plans to invest more than $2 billion in China through 2012 in research and development, technology and financial services partnerships. The move marks GE’s “confidence in China’s long-term …